By using this site, you agree to the Privacy Policy and Terms of Use.
Accept

News Junction

Notification Show More
Font ResizerAa
  • Home
  • World News
    World NewsShow More
    Asian markets stagger into weekend as trade rally runs out of legs
    Asian markets stagger into weekend as trade rally runs out of legs
    May 16, 2025
    Baby KJ was born with a rare, deadly disease. Doctors designed a fix – just for him
    Baby KJ was born with a rare, deadly disease. Doctors designed a fix – just for him
    May 16, 2025
    FIFA president Gianni Infantino criticised by European football chiefs over decision to join Donald Trump tour | World News
    FIFA president Gianni Infantino criticised by European football chiefs over decision to join Donald Trump tour | World News
    May 16, 2025
    Arctic Worries: Melting Ice, and a Russia-China Partnership
    Arctic Worries: Melting Ice, and a Russia-China Partnership
    May 16, 2025
    Largest US retailer Walmart warns of price hikes because of tariffs | Trade War News
    Largest US retailer Walmart warns of price hikes because of tariffs | Trade War News
    May 15, 2025
  • Business
    BusinessShow More
    Ukraine blows up bridges to consolidate its positions in Russia
    Ukraine blows up bridges to consolidate its positions in Russia
    August 18, 2024
    Commentary: AI phones from Google and Apple will erode trust in everything
    Commentary: AI phones from Google and Apple will erode trust in everything
    August 18, 2024
    The most famous Indian Dishes – Insights Success
    The most famous Indian Dishes – Insights Success
    August 18, 2024
    Life on the road as a female long rides cyclist
    Life on the road as a female long rides cyclist
    August 18, 2024
    UK inflation rises to 2.2%
    UK inflation rises to 2.2%
    August 18, 2024
  • Cryptocurrency
    CryptocurrencyShow More
    Tornado Cash dev Roman Storm trial goes ahead with slight trim
    Tornado Cash dev Roman Storm trial goes ahead with slight trim
    May 16, 2025
    Bitcoin to outperform gold in second half of 2025: JP Morgan
    Bitcoin to outperform gold in second half of 2025: JP Morgan
    May 16, 2025
    FTX Token surges 14% ahead of B creditor distribution
    FTX Token surges 14% ahead of $5B creditor distribution
    May 16, 2025
    Could Ruvi AI (RUVI) Be the Next Dogecoin (DOGE)? Analysts Suggest it Will Skyrocket by 20,000% During Altcoin Season
    Could Ruvi AI (RUVI) Be the Next Dogecoin (DOGE)? Analysts Suggest it Will Skyrocket by 20,000% During Altcoin Season
    May 16, 2025
    Bitcoin Long-Term Holders Supply Sees Second Consecutive Decline After Period Of Growth
    Bitcoin Long-Term Holders Supply Sees Second Consecutive Decline After Period Of Growth
    May 16, 2025
  • Technology
    TechnologyShow More
    How to Improve Your Spotify Recommendations
    How to Improve Your Spotify Recommendations
    August 18, 2024
    X says it’s closing operations in Brazil
    X says it’s closing operations in Brazil
    August 18, 2024
    Supermoon set to rise: Top tips for amateur photographers | Science & Tech News
    Supermoon set to rise: Top tips for amateur photographers | Science & Tech News
    August 18, 2024
    Scientists Want to See Videos of Your Cat for a New Study
    Scientists Want to See Videos of Your Cat for a New Study
    August 18, 2024
    OpenAI’s new voice mode let me talk with my phone, not to it
    OpenAI’s new voice mode let me talk with my phone, not to it
    August 18, 2024
  • Entertainment
  • Sports News
  • People
  • Trend
Reading: Fennec Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 13, 2024
Share
Font ResizerAa

News Junction

  • World News
  • Business
  • Technology
  • Cryptocurrency
  • Trend
  • Entertainment
Search
  • Recent Headlines in Entertainment, World News, and Cryptocurrency – NewsJunction
  • World News
  • Business
  • Cryptocurrency
  • Technology
  • Entertainment
  • Sports News
  • People
  • Trend
Have an existing account? Sign In
Follow US
News Junction > Blog > Business > Fennec Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 13, 2024
Fennec Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 13, 2024
Business

Fennec Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 13, 2024

Published August 7, 2024
Share
3 Min Read
SHARE

Article content

Company to Also Participate in 2024 Wedbush PacGrow Healthcare Conference

RESEARCH TRIANGLE PARK, N.C., Aug. 06, 2024 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its second quarter 2024 financial results and provide a business update before the opening of the U.S. financial markets on Tuesday, August 13, 2024. Management will host a conference call and webcast that day to discuss the Company’s financial and business results.

Article content

Conference Call & Webcast Detail:

To access the conference call, please register using https://register.vevent.com/register/BI59b5706a6c00453a9eed343d4a210de9. Upon registration, a dial-in number and unique PIN will be provided to join the call. To access the live webcast link, log onto www.fennepharma.com and proceed to the News & Events / Event Calendar page under the Investors & Media heading. Please connect to the company’s website at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to listen to the webcast. A webcast replay of the conference call will also be archived on www.fennecpharma.com for thirty days.

2024 Wedbush PacGrow Healthcare Conference Participation:

Fennec also announced that it will participate in the 2024 Wedbush PacGrow Healthcare Conference taking place August 13-14, 2024, in New York, NY.

About Fennec Pharmaceuticals
Fennec Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development and commercialization of PEDMARK® and Pedmarqsi to reduce the risk of platinum-induced ototoxicity in pediatric patients. Further, PEDMARK received FDA approval in September 2022 and European Commission Marketing Authorization in June 2023 for Pedmarqsi. PEDMARK has received Orphan Drug Exclusivity in the U.S. for seven years of market protection and Pedmarqsi has received Pediatric Use Marketing Authorization in Europe which includes eight years plus two years of data and market protection. Fennec has a license agreement with Oregon Health and Science University (OHSU) for exclusive worldwide license rights to intellectual property directed to sodium thiosulfate and its use for chemoprotection, including the reduction of risk of ototoxicity induced by platinum chemotherapy, in humans. For more information, please visit www.fennecpharma.com.

For further information, please contact:

Investors:
Robert Andrade
Chief Financial Officer
Fennec Pharmaceuticals Inc.
+1 919-246-5299

Corporate and Media:
Lindsay Rocco
Elixir Health Public Relations
+1 862-596-1304
lrocco@elixirhealthpr.com

Share this article in your social network

#Fennec #Pharmaceuticals #Report #Quarter #Financial #Results #August

TAGGED:AugustFennecFinancialPharmaceuticalsQuarterreportResults
Share This Article
Facebook Twitter Pinterest Whatsapp Whatsapp LinkedIn Email Copy Link Print
Share
What do you think?
Love0
Sad0
Happy0
Sleepy0
Angry0
Dead0
Wink0
Previous Article Core Scientific surges 17% after latest CoreWeave announcement Core Scientific surges 17% after latest CoreWeave announcement
Next Article Elon Musk’s X Sues Advertisers Over Alleged Boycott Elon Musk’s X Sues Advertisers Over Alleged Boycott
- Advertisement -

Latest Post

Asian markets stagger into weekend as trade rally runs out of legs
Asian markets stagger into weekend as trade rally runs out of legs
World News
Tornado Cash dev Roman Storm trial goes ahead with slight trim
Tornado Cash dev Roman Storm trial goes ahead with slight trim
Cryptocurrency
Baby KJ was born with a rare, deadly disease. Doctors designed a fix – just for him
Baby KJ was born with a rare, deadly disease. Doctors designed a fix – just for him
World News
Bitcoin to outperform gold in second half of 2025: JP Morgan
Bitcoin to outperform gold in second half of 2025: JP Morgan
Cryptocurrency
FTX Token surges 14% ahead of B creditor distribution
FTX Token surges 14% ahead of $5B creditor distribution
Cryptocurrency
FIFA president Gianni Infantino criticised by European football chiefs over decision to join Donald Trump tour | World News
FIFA president Gianni Infantino criticised by European football chiefs over decision to join Donald Trump tour | World News
World News
- Advertisement -

You Might Also Like

‘I let down the community’: Ex-OpenSea manager convicted in first-ever NFT insider-trading case is sentenced
Business

‘I let down the community’: Ex-OpenSea manager convicted in first-ever NFT insider-trading case is sentenced

August 23, 2023
Canadian Immigrant Magazine honours Sam Primucci with its Entrepreneur of the Year and Top 25 Canadian Immigrant awards
Business

Canadian Immigrant Magazine honours Sam Primucci with its Entrepreneur of the Year and Top 25 Canadian Immigrant awards

August 4, 2023
Banking in the eyes of NextGen client
Business

Banking in the eyes of NextGen client

August 7, 2024
Maker of 0 Golf Putter Tumbles After Surging 624% in Stock Debut
Business

Maker of $400 Golf Putter Tumbles After Surging 624% in Stock Debut

August 17, 2023

About Us

NEWS JUNCTION (NewsJunction.xyz) Your trusted destination for global news. Stay informed with our timely and accurate reporting on diverse topics, including politics, technology, science, entertainment, sports, and more. Count on us for unbiased and reliable updates at your fingertips.

Quick Link

  • About
  • Disclaimer
  • Privacy Policy
  • Terms of Use
  • Contact

Top Categories

  • World News
  • Business
  • Technology
  • Entertainment
  • Cryptocurrency
  • Sports News
  • Trend
  • People

Subscribe

Subscribe to our newsletter to get our newest articles instantly!

    © 2023 News Junction.
    • Blog
    • Advertise
    • Contact
    Welcome Back!

    Sign in to your account

    Username or Email Address
    Password

    Lost your password?